Principaux concurrents
PER (N) Price to Book (N) PEG (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Rendement du dividende (N) Capi.($)
20.83x4.03x-2.44x6.36x13.92x16.04x1,53% 55,27 Md
32.72x6.11x0.93x8.17x25.61x25.9x0,05% 54,15 Md
-41.75x53.9x0.69x13.26x-39.07x-42.86x-.--% 23,11 Md
-18.34x1.12x2.76x4.38x-7.67x-6.47x-.--% 23,22 Md
25.44x2.49x1.86x5.01x13.23x15.82x-.--% 20,33 Md
24.96x2.83x-1.18x4.84x15.73x17.74x-.--% 17,91 Md
-612.56x22.03x11.08x37.5x-1557.05x-461.96x-.--% 15,76 Md
45.31x11.62x0.4x18.35x47.24x43.34x0,08% 15 Md
17.3x4.92x1.21x5.01x11.68x12.92x-.--% 13,82 Md
-13.01x153.02x0.63x3408.95x-16.01x-13.07x-.--% 11,44 Md
3323.87x8.13x-32.56x14.42x89.34x299.51x-.--% 11,62 Md
-12.84x-89.29x6.03x93.67x-14.6x-14.19x-.--% 11,16 Md
-27.53x29.49x-0x26.05x-32.9x-26.48x-.--% 12,49 Md
-32.27x8.87x-0.58x - -29.84x-28.87x-.--% 8,72 Md
12.31x6.06x0.03x8.05x12.94x12.01x-.--% 8,9 Md
-17.74x8.82x3.8x113.77x-15.91x-14.46x - 8,83 Md
22.32x6.06x1.06x - - - 0,35% 8,72 Md
-8.84x - -0.07x - - - - 7,87 Md
-6.58x - -0.13x - -6.74x-6.2x-.--% 8,09 Md
Moyenne 143,87x 14,13x -0,34x 251,19x -87,65x -10,08x 0,12% 17,71 Md
Moyenne pondérée par Capi. 93,61x 12,47x -0,17x 145,01x -69,12x -6,71x 0,29%
Médicaments bio-thérapeutiques